Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas

Weiliang He, Ran Liu, Shao Hua Yang, Fang Yuan

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Tamoxifen, a selective estrogen receptor modulator, is widely used in the chemotherapy of estrogen receptor-positive breast cancer. Recent studies have indicated that tamoxifen might have a potential chemotherapeutic effect on glioma. In the present study, we determined the chemotherapeutic action of tamoxifen on human glioma cell lines. Methylation of 06-methylguanine-DNA methyltransferase was identified in A172, U251, and BT325 glioma cell lines, but not in the U87 cell line. Consistently, A172, U251, and BT325 cell lines are resistant to temozolomide. Tamoxifen induced significant cytotoxic action in A172, U251, BT325, and U87 cell lines. Further, Hoechst 33342 staining and apoptosis flow cytometric analysis demonstrated that tamoxifen induced apoptosis in the BT325 cell line. Mitochondrial complex analysis indicated that tamoxifen, but not other estrogen receptor modulators, dose-dependently inhibits complex I activity. In summary, our study suggests that tamoxifen might have a chemotherapeutic effect on temozolomide-resistant glioma through its direct action on mitochondrial complex I inhibition and could provide further evidence to support future clinical trials of tamoxifen for the treatment of glioblastoma.

Original languageEnglish
Pages (from-to)293-300
Number of pages8
JournalAnti-Cancer Drugs
Volume26
Issue number3
DOIs
StatePublished - Mar 2015

Fingerprint

temozolomide
Tamoxifen
Glioma
Cell Line
Apoptosis
Selective Estrogen Receptor Modulators
Estrogen Receptor Modulators
Methyltransferases
Glioblastoma
Estrogen Receptors
Methylation

Keywords

  • glioma
  • mitochondria
  • tamoxifen
  • temozolomide

Cite this

@article{e06bd4461cd14d2da16a813f573a15a1,
title = "Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas",
abstract = "Tamoxifen, a selective estrogen receptor modulator, is widely used in the chemotherapy of estrogen receptor-positive breast cancer. Recent studies have indicated that tamoxifen might have a potential chemotherapeutic effect on glioma. In the present study, we determined the chemotherapeutic action of tamoxifen on human glioma cell lines. Methylation of 06-methylguanine-DNA methyltransferase was identified in A172, U251, and BT325 glioma cell lines, but not in the U87 cell line. Consistently, A172, U251, and BT325 cell lines are resistant to temozolomide. Tamoxifen induced significant cytotoxic action in A172, U251, BT325, and U87 cell lines. Further, Hoechst 33342 staining and apoptosis flow cytometric analysis demonstrated that tamoxifen induced apoptosis in the BT325 cell line. Mitochondrial complex analysis indicated that tamoxifen, but not other estrogen receptor modulators, dose-dependently inhibits complex I activity. In summary, our study suggests that tamoxifen might have a chemotherapeutic effect on temozolomide-resistant glioma through its direct action on mitochondrial complex I inhibition and could provide further evidence to support future clinical trials of tamoxifen for the treatment of glioblastoma.",
keywords = "glioma, mitochondria, tamoxifen, temozolomide",
author = "Weiliang He and Ran Liu and Yang, {Shao Hua} and Fang Yuan",
year = "2015",
month = "3",
doi = "10.1097/CAD.0000000000000197",
language = "English",
volume = "26",
pages = "293--300",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "3",

}

Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas. / He, Weiliang; Liu, Ran; Yang, Shao Hua; Yuan, Fang.

In: Anti-Cancer Drugs, Vol. 26, No. 3, 03.2015, p. 293-300.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas

AU - He, Weiliang

AU - Liu, Ran

AU - Yang, Shao Hua

AU - Yuan, Fang

PY - 2015/3

Y1 - 2015/3

N2 - Tamoxifen, a selective estrogen receptor modulator, is widely used in the chemotherapy of estrogen receptor-positive breast cancer. Recent studies have indicated that tamoxifen might have a potential chemotherapeutic effect on glioma. In the present study, we determined the chemotherapeutic action of tamoxifen on human glioma cell lines. Methylation of 06-methylguanine-DNA methyltransferase was identified in A172, U251, and BT325 glioma cell lines, but not in the U87 cell line. Consistently, A172, U251, and BT325 cell lines are resistant to temozolomide. Tamoxifen induced significant cytotoxic action in A172, U251, BT325, and U87 cell lines. Further, Hoechst 33342 staining and apoptosis flow cytometric analysis demonstrated that tamoxifen induced apoptosis in the BT325 cell line. Mitochondrial complex analysis indicated that tamoxifen, but not other estrogen receptor modulators, dose-dependently inhibits complex I activity. In summary, our study suggests that tamoxifen might have a chemotherapeutic effect on temozolomide-resistant glioma through its direct action on mitochondrial complex I inhibition and could provide further evidence to support future clinical trials of tamoxifen for the treatment of glioblastoma.

AB - Tamoxifen, a selective estrogen receptor modulator, is widely used in the chemotherapy of estrogen receptor-positive breast cancer. Recent studies have indicated that tamoxifen might have a potential chemotherapeutic effect on glioma. In the present study, we determined the chemotherapeutic action of tamoxifen on human glioma cell lines. Methylation of 06-methylguanine-DNA methyltransferase was identified in A172, U251, and BT325 glioma cell lines, but not in the U87 cell line. Consistently, A172, U251, and BT325 cell lines are resistant to temozolomide. Tamoxifen induced significant cytotoxic action in A172, U251, BT325, and U87 cell lines. Further, Hoechst 33342 staining and apoptosis flow cytometric analysis demonstrated that tamoxifen induced apoptosis in the BT325 cell line. Mitochondrial complex analysis indicated that tamoxifen, but not other estrogen receptor modulators, dose-dependently inhibits complex I activity. In summary, our study suggests that tamoxifen might have a chemotherapeutic effect on temozolomide-resistant glioma through its direct action on mitochondrial complex I inhibition and could provide further evidence to support future clinical trials of tamoxifen for the treatment of glioblastoma.

KW - glioma

KW - mitochondria

KW - tamoxifen

KW - temozolomide

UR - http://www.scopus.com/inward/record.url?scp=84925538003&partnerID=8YFLogxK

U2 - 10.1097/CAD.0000000000000197

DO - 10.1097/CAD.0000000000000197

M3 - Article

C2 - 25535979

AN - SCOPUS:84925538003

VL - 26

SP - 293

EP - 300

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 3

ER -